The Drug Supply Chain Security Act (DSCSA) will be actively enforced in just six months, and it is set to revolutionise how drugs are distributed throughout the US.

Companies that are yet to develop an in-house solution are realizing that employing contract service providers, which are well-prepared for new serialization legislation, is a viable solution to tackling the now very tight timescales and ensuring continuity of supply to market. Alongside other industry leaders, Dexter Tjoa, Director Corporate Strategy, talks to World Pharma Today about how pharma businesses are working towards compliance.

You can read the article in full here.

‍